What is Arcturus Therapeutics Holdings Inc. Common Stock's Net Income (TTM)?

Arcturus Therapeutics Holdings Inc. Common Stock's Net Income (TTM) is -$93.3M, based on as-reported figures from SEC (XBRL) filings.

What is Arcturus Therapeutics Holdings Inc. Common Stock's Diluted EPS (TTM)?

Arcturus Therapeutics Holdings Inc. Common Stock's Diluted EPS (TTM) is -3.28, based on as-reported figures from SEC (XBRL) filings.

What is Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA Margin?

Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA Margin is -339.0%, based on as-reported figures from SEC (XBRL) filings.

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Financial Statements

Arcturus Therapeutics Holdings Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00NNW8JL0

XNAS · usd

15.63▼ 0.19 (-1.20%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close15.82

Day's Range14.77 – 15.86

52-Week Range5.50 – 24.17

Volume641.2K

Avg Volume1.2M

Share Statistics

Shares Outstanding

Employees111

ExchangeXNAS

Listed2013-05-22

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Arcturus Therapeutics Holdings Inc. Common Stock (ARCT)

What is Arcturus Therapeutics Holdings Inc. Common Stock's Market Cap?: Arcturus Therapeutics Holdings Inc. Common Stock's Market Cap is $444.3M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Price / Sales?: Arcturus Therapeutics Holdings Inc. Common Stock's Price / Sales is 15.1×, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Revenue (TTM)?: Arcturus Therapeutics Holdings Inc. Common Stock's Revenue (TTM) is $29.4M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Net Income (TTM)?: Arcturus Therapeutics Holdings Inc. Common Stock's Net Income (TTM) is -$93.3M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA?: Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA is -$99.5M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Diluted EPS (TTM)?: Arcturus Therapeutics Holdings Inc. Common Stock's Diluted EPS (TTM) is -3.28, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA Margin?: Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA Margin is -339.0%, based on as-reported figures from SEC (XBRL) filings.